skip to main content
Idioma:
Mostrar Somente
Refinado por: Base de dados/Biblioteca: HEAL-Link subscriptions: Lippincott Williams & Wilkins remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Review of gynecologic and reproductive care for women with developmental disabilities
Review of gynecologic and reproductive care for women with developmental disabilities
Material Type:
Artigo 		Adicionar ao Meu Espaço

Review of gynecologic and reproductive care for women with developmental disabilities

Abells, Dara ; Kirkham, Yolanda A ; Ornstein, Melanie P

Current opinion in obstetrics & gynecology, 2016-10, Vol.28 (5), p.350-358 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
2
First-line PD1/PD-L1 inhibitors for platinum-ineligible advanced urothelial carcinoma (UC)
First-line PD1/PD-L1 inhibitors for platinum-ineligible advanced urothelial carcinoma (UC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-line PD1/PD-L1 inhibitors for platinum-ineligible advanced urothelial carcinoma (UC)

Agarwal, Archana ; Pond, Gregory Russell ; Drakaki, Alexandra ; Lee, Jae-Lyun ; Bilen, Mehmet Asim ; Di Lorenzo, Giuseppe ; Grivas, Petros ; Ornstein, Moshe Chaim ; Barata, Pedro C. ; Gupta, Shilpa ; Hussain, Syed A. ; Curran, Catherine ; Garcia, Jorge A. ; Sonpavde, Guru

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.432-432 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
3
First-line PD(L)1 inhibitors for platinum-ineligible advanced urothelial carcinoma (aUC)
First-line PD(L)1 inhibitors for platinum-ineligible advanced urothelial carcinoma (aUC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-line PD(L)1 inhibitors for platinum-ineligible advanced urothelial carcinoma (aUC)

Agarwal, Archana ; Pond, Gregory Russell ; Gupta, Ruby ; Ornstein, Moshe Chaim ; Barata, Pedro C. ; Garcia, Jorge A. ; Drakaki, Alexandra ; Lee, Jae-Lyun ; Kanesvaran, Ravindran ; Bilen, Mehmet Asim ; Lorenzo, Felipe R. ; Grivas, Petros ; Hussain, Syed A. ; Curran, Catherine ; Sonpavde, Guru

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e16024-e16024 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
Prognostic factors and clinical outcomes in patients with upper tract urothelial carcinoma undergoing surgery: The Cleveland Clinic experience
Prognostic factors and clinical outcomes in patients with upper tract urothelial carcinoma undergoing surgery: The Cleveland Clinic experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factors and clinical outcomes in patients with upper tract urothelial carcinoma undergoing surgery: The Cleveland Clinic experience

Ahmed, Ramsha ; Sheu, Michael ; Wei, Wei ; Ornstein, Moshe Chaim ; Gilligan, Timothy D. ; Dima, Danai ; Campbell, Steven ; Lee, Byron H ; Weight, Christopher ; Wee, Christopher Eing ; Mian, Omar Y. ; Kaouk, Jihad ; Haber, Georges-Pascal ; Gupta, Shilpa

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4593-4593 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Impact of neoadjuvant chemotherapy on pathologic outcomes in patients with upper tract urothelial carcinoma undergoing extirpative surgery
Impact of neoadjuvant chemotherapy on pathologic outcomes in patients with upper tract urothelial carcinoma undergoing extirpative surgery
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of neoadjuvant chemotherapy on pathologic outcomes in patients with upper tract urothelial carcinoma undergoing extirpative surgery

Almassi, Nima ; Gao, Tianming ; Lee, Byron ; Stein, Robert ; Haber, Georges-Pascal ; Ornstein, Moshe Chaim ; Rini, Brian I. ; Gilligan, Timothy D. ; Garcia, Jorge A. ; Stephenson, Andrew J. ; Grivas, Petros

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.457-457 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Intra-patient heterogeneity in urothelial cancer (UC) circulating tumor cells (CTC) and PDL1 expression to identify biomarkers of response and new therapeutic targets: A pilot study
Intra-patient heterogeneity in urothelial cancer (UC) circulating tumor cells (CTC) and PDL1 expression to identify biomarkers of response and new therapeutic targets: A pilot study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intra-patient heterogeneity in urothelial cancer (UC) circulating tumor cells (CTC) and PDL1 expression to identify biomarkers of response and new therapeutic targets: A pilot study

Arafat, Waddah ; Stahlfeld, Charlotte ; Sperger, Jamie M ; Heninger, Erika ; Gopalakrishnan, Dharmesh ; Barata, Pedro C. ; Lamenza, Marcelo ; Devonshire, Sarah ; Hoxha, Nita ; Profusek, Pam ; Rini, Brian I. ; Ornstein, Moshe Chaim ; Garcia, Jorge A. ; Kyriakopoulos, Christos ; Lang, Joshua Michael ; Grivas, Petros

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4537-4537 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)

Atkins, Michael B ; Jegede, Opeyemi A ; Haas, Naomi B ; McDermott, David F ; Bilen, Mehmet A ; Stein, Mark ; Sosman, Jeffrey A ; Alter, Robert ; Plimack, Elizabeth R ; Ornstein, Moshe ; Hurwitz, Michael ; Peace, David J ; Signoretti, Sabina ; Denize, Thomas ; Cimadamore, Alessia ; Wu, Catherine J ; Braun, David ; Einstein, David ; Catalano, Paul J ; Hammers, Hans

Journal of clinical oncology, 2022-09, Vol.40 (25), p.2913-2923 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
8
Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced non-clear cell renal cell carcinoma (nccRCC) (HCRN GU16-260-Cohort B)
Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced non-clear cell renal cell carcinoma (nccRCC) (HCRN GU16-260-Cohort B)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced non-clear cell renal cell carcinoma (nccRCC) (HCRN GU16-260-Cohort B)

Atkins, Michael B. ; Jegede, Opeyemi ; Haas, Naomi B. ; McDermott, David F. ; Bilen, Mehmet Asim ; Hawley, Jessica ; Sosman, Jeffrey A. ; Alter, Robert S. ; Plimack, Elizabeth R. ; Ornstein, Moshe Chaim ; Hurwitz, Michael E. ; Peace, David J. ; Signoretti, Sabina ; Wu, Catherine J. ; Catalano, Paul J. ; Hammers, Hans J.

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4510-4510 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced clear cell renal cell (HCRN GU16-260-Cohort A): Final report
Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced clear cell renal cell (HCRN GU16-260-Cohort A): Final report
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced clear cell renal cell (HCRN GU16-260-Cohort A): Final report

Atkins, Michael B. ; Jegede, Opeyemi ; Haas, Naomi B. ; McDermott, David F. ; Bilen, Mehmet Asim ; Stein, Mark N. ; Sosman, Jeffrey Alan ; Alter, Robert S. ; Plimack, Elizabeth R. ; Ornstein, Moshe Chaim ; Hurwitz, Michael E. ; Peace, David J. ; Signoretti, Sabina ; Denize, Thomas ; Cimadamore, Alessia ; Braun, David A. ; Wu, Catherine J. ; Einstein, David Johnson ; Catalano, Paul J. ; Hammers, Hans J.

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.288-288 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Treatment-free survival (TFS) outcomes from the phase II study of nivolumab and salvage nivolumab + ipilimumab in advanced clear cell renal cell carcinoma (aRCC) (HCRN GU16-260-Cohort A)
Treatment-free survival (TFS) outcomes from the phase II study of nivolumab and salvage nivolumab + ipilimumab in advanced clear cell renal cell carcinoma (aRCC) (HCRN GU16-260-Cohort A)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment-free survival (TFS) outcomes from the phase II study of nivolumab and salvage nivolumab + ipilimumab in advanced clear cell renal cell carcinoma (aRCC) (HCRN GU16-260-Cohort A)

Atkins, Michael B. ; Jegede, Opeyemi ; McDermott, David F. ; Haas, Naomi B. ; Bilen, Mehmet Asim ; Stein, Mark N. ; Sosman, Jeffrey A. ; Plimack, Elizabeth R. ; Alter, Robert S. ; Ornstein, Moshe Chaim ; Hurwitz, Michael E. ; Peace, David J. ; Einstein, David Johnson ; Catalano, Paul J. ; Hammers, Hans J. ; Regan, Meredith M.

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.604-604 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (283)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (289)
  2. Resenhas  (4)
  3. Reports  (1)
  4. Anais de Congresso  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1987  (23)
  2. 1987Até1994  (57)
  3. 1995Até2002  (53)
  4. 2003Até2012  (46)
  5. Após 2012  (117)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.